Lakefront Biotherapeutics, formerly Galapagos, rebranded and acquired Ouro Medicines' assets with Gilead, creating a new drug development platform. The company has €2.24 billion in liquidity to support clinical trials for gamgertamig, a drug targeting tough autoimmune diseases. While promising, gamgertamig's long-term efficacy and safety remain unproven, making future value dependent on clinical success and careful capital use. The company's current valuation reflects development risks, with upside tied to progress and avoiding costly acquisitions.
Lakefront Biotherapeutics is noted here with a focus on its €2.24 billion liquidity supporting drug development. For readers following the health sector, here is Pluang's market snapshot as of Sep 15, 2026 18:13 WIB: out of 91 priced US health stocks, 31 rose and 54 fell. Notable movers include Eli Lilly And Co (LLY) up 1.65% at USD 1,156.50, ResMed Inc. (RMD) up 1.57% at USD 226.48, and Ginkgo Bioworks Holdings Inc. (DNA) down 2.14% at USD 6.86.
SU Group Holdings Limited has become the exclusive distributor of HDX's TRACELINE PX3 Portable X-Ray System in Hong Kong and Macau. This marks SU Group's second international distribution deal in 2026, following a partnership with Germany's GEZE. The...
EraNova Metals has filed an independent NI 43-101 technical report confirming robust economics for its 100% owned Adanac Molybdenum Project in British Columbia. The Preliminary Economic Assessment shows a pre-tax NPV of C$1.2 billion and an IRR of 30...
Wall Street analysts overwhelmingly rate Meta as a Buy, with 55 Buy ratings, 7 Holds, and no Sell recommendations. The consensus price target is $805.90, implying a 24.36% upside from the current price of around $660. Meta's recent Q2 report showed s...
Stocks of major data center REITs Digital Realty and Equinix dropped after AI companies Anthropic, OpenAI, and xAI signaled a slowdown in AI development. Despite this, Digital Realty's CEO Andrew Power emphasized that AI growth and related real estat...
Gen Zers are migrating to cities with strong job markets such as San Antonio, Washington, D.C., and Austin, prioritizing career opportunities and vibrant social scenes. Millennials, meanwhile, prefer metros like Houston and Dallas where housing is mo...
